{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:18:15Z","timestamp":1793017095731,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670768"],"award-info":[{"award-number":["81670768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21961142009"],"award-info":[{"award-number":["21961142009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR18H160003"],"award-info":[{"award-number":["LR18H160003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hyperglycemia activates toll-like receptor 4 (TLR4) to induce inflammation in diabetic cardiomyopathy (DCM). However, the mechanisms of TLR4 activation remain unclear. Here we examine the role of myeloid differentiation 2 (MD2), a co-receptor of TLR4, in high glucose (HG)- and diabetes-induced inflammatory cardiomyopathy. We show increased MD2 in heart tissues of diabetic mice and serum of human diabetic subjects. MD2 deficiency in mice inhibits TLR4 pathway activation, which correlates with reduced myocardial remodeling and improved cardiac function. Mechanistically, we show that HG induces extracellular advanced glycation end products (AGEs), which bind directly to MD2, leading to formation of AGEs-MD2-TLR4 complex and initiation of pro-inflammatory pathways. We further detect elevated AGE-MD2 complexes in heart tissues and serum of diabetic mice and human subjects with DCM. In summary, we uncover a new mechanism of HG-induced inflammatory responses and myocardial injury, in which AGE products directly bind MD2 to drive inflammatory DCM.<\/jats:p>","DOI":"10.1038\/s41467-020-15978-3","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T06:02:39Z","timestamp":1588312959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy"],"prefix":"10.1038","volume":"11","author":[{"given":"Yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaojun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-849X","authenticated-orcid":false,"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"15978_CR1","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2337\/dc14-1720","volume":"37","author":"SD de Ferranti","year":"2014","unstructured":"de Ferranti, S. D. et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care 37, 2843\u20132863 (2014).","journal-title":"Diabetes Care"},{"key":"15978_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger, H. & Abel, E. D. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57, 660\u2013671 (2014).","journal-title":"Diabetologia"},{"key":"15978_CR3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2337\/db11-0477","volume":"61","author":"M Rajesh","year":"2012","unstructured":"Rajesh, M. et al. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes 61, 716\u2013727 (2012).","journal-title":"Diabetes"},{"key":"15978_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2337\/db06-1163","volume":"56","author":"D Westermann","year":"2007","unstructured":"Westermann, D. et al. Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes 56, 641\u2013646 (2007).","journal-title":"Diabetes"},{"key":"15978_CR5","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.2337\/db06-1662","volume":"56","author":"D Westermann","year":"2007","unstructured":"Westermann, D. et al. Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy. Diabetes 56, 1834\u20131841 (2007).","journal-title":"Diabetes"},{"key":"15978_CR6","doi-asserted-by":"publisher","first-page":"e0120849","DOI":"10.1371\/journal.pone.0120849","volume":"10","author":"Y Jia","year":"2015","unstructured":"Jia, Y. et al. SIRT1 is a regulator in high glucose-induced inflammatory response in RAW264.7 cells. PLoS ONE 10, e0120849 (2015).","journal-title":"PLoS ONE"},{"key":"15978_CR7","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.2337\/diabetes.50.6.1472","volume":"50","author":"H Nakagami","year":"2001","unstructured":"Nakagami, H. et al. Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes 50, 1472\u20131481 (2001).","journal-title":"Diabetes"},{"key":"15978_CR8","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2337\/db13-1577","volume":"63","author":"Y Pan","year":"2014","unstructured":"Pan, Y. et al. Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy. Diabetes 63, 3497\u20133511 (2014).","journal-title":"Diabetes"},{"key":"15978_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.trsl.2015.04.011","volume":"167","author":"SM Cabrera","year":"2016","unstructured":"Cabrera, S. M., Henschel, A. M. & Hessner, M. J. Innate inflammation in type 1 diabetes. Transl. Res. 167, 214\u2013227 (2016).","journal-title":"Transl. Res."},{"key":"15978_CR10","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1038\/emm.2013.97","volume":"45","author":"BS Park","year":"2013","unstructured":"Park, B. S. & Lee, J.-O. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp. Mol. Med. 45, e66 (2013).","journal-title":"Exp. Mol. Med."},{"key":"15978_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/aps.2014.127","volume":"36","author":"Z-w Liu","year":"2015","unstructured":"Liu, Z.-w et al. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS\/TLR-4 signaling pathway. Acta Pharm. Sin. 36, 323\u2013333 (2015).","journal-title":"Acta Pharm. Sin."},{"key":"15978_CR12","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.2337\/db08-0564","volume":"57","author":"MR Dasu","year":"2008","unstructured":"Dasu, M. R., Devaraj, S., Zhao, L., Hwang, D. H. & Jialal, I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57, 3090\u20133098 (2008).","journal-title":"Diabetes"},{"key":"15978_CR13","doi-asserted-by":"publisher","first-page":"790902","DOI":"10.1155\/2014\/790902","volume":"2014","author":"U Rajamani","year":"2014","unstructured":"Rajamani, U. & Jialal, I. Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy. J. Diabetes Res. 2014, 790902 (2014).","journal-title":"J. Diabetes Res."},{"key":"15978_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1681\/ASN.2010111210","volume":"23","author":"M Lin","year":"2012","unstructured":"Lin, M. et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J. Am. Soc. Nephrol. 23, 86\u2013102 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"15978_CR15","doi-asserted-by":"publisher","first-page":"F1145","DOI":"10.1152\/ajprenal.00319.2012","volume":"303","author":"H Kaur","year":"2012","unstructured":"Kaur, H., Chien, A. & Jialal, I. Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 303, F1145\u2013F1150 (2012).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"15978_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/dc09-1799","volume":"33","author":"MR Dasu","year":"2010","unstructured":"Dasu, M. R., Devaraj, S., Park, S. & Jialal, I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33, 861\u2013868 (2010).","journal-title":"Diabetes Care"},{"key":"15978_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-133","volume":"8","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4. J. Transl. Med. 8, 133 (2010).","journal-title":"J. Transl. Med."},{"key":"15978_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/aps.2014.127","volume":"36","author":"ZW Liu","year":"2015","unstructured":"Liu, Z. W. et al. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS\/TLR-4 signaling pathway. Acta Pharm. Sin. 36, 323\u2013333 (2015).","journal-title":"Acta Pharm. Sin."},{"key":"15978_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00395-007-0673-0","volume":"102","author":"D Westermann","year":"2007","unstructured":"Westermann, D. et al. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res. Cardiol. 102, 500\u2013507 (2007).","journal-title":"Basic Res. Cardiol."},{"key":"15978_CR20","doi-asserted-by":"publisher","first-page":"H1036","DOI":"10.1152\/ajpheart.00340.2014","volume":"307","author":"CM Thomas","year":"2014","unstructured":"Thomas, C. M. et al. Cardiac-specific suppression of NF-kappaB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system. Am. J. Physiol. Heart Circulatory Physiol. 307, H1036\u2013H1045 (2014).","journal-title":"Am. J. Physiol. Heart Circulatory Physiol."},{"key":"15978_CR21","doi-asserted-by":"publisher","unstructured":"Pan, Y. et al. Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy. Diabetes, https:\/\/doi.org\/10.2337\/db13-1577 (2014).","DOI":"10.2337\/db13-1577"},{"key":"15978_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1042\/CS20130267","volume":"126","author":"H Mudaliar","year":"2014","unstructured":"Mudaliar, H., Pollock, C. & Panchapakesan, U. Role of Toll-like receptors in diabetic nephropathy. Clin. Sci. 126, 685\u2013694 (2014).","journal-title":"Clin. Sci."},{"key":"15978_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13997","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat. Commun. 8, 13997 (2017).","journal-title":"Nat. Commun."},{"key":"15978_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-016-0599-5","volume":"112","author":"J Han","year":"2017","unstructured":"Han, J. et al. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4\/NF-kappaB signaling pathway. Basic Res. Cardiol. 112, 9 (2017).","journal-title":"Basic Res. Cardiol."},{"key":"15978_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jnutbio.2019.04.003","volume":"70","author":"S Xu","year":"2019","unstructured":"Xu, S. et al. MD2 blockade prevents oxLDL-induced renal epithelial cell injury and protects against high-fat-diet-induced kidney dysfunction. J. Nutr. Biochem. 70, 47\u201355 (2019).","journal-title":"J. Nutr. Biochem."},{"key":"15978_CR26","doi-asserted-by":"publisher","first-page":"e0126580","DOI":"10.1371\/journal.pone.0126580","volume":"10","author":"MA Venneri","year":"2015","unstructured":"Venneri, M. A. et al. Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice. PLoS ONE 10, e0126580 (2015).","journal-title":"PLoS ONE"},{"key":"15978_CR27","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1111\/bph.13221","volume":"172","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis. Br. J. Pharmacol. 172, 4391\u20134405 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"15978_CR28","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1159\/000373972","volume":"35","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Enhancement of LPS-induced microglial inflammation response via TLR4 under high glucose conditions. Cell Physiol. Biochem. 35, 1571\u20131581 (2015).","journal-title":"Cell Physiol. Biochem."},{"key":"15978_CR29","doi-asserted-by":"publisher","first-page":"7815","DOI":"10.1073\/pnas.88.17.7815","volume":"88","author":"JW Slot","year":"1991","unstructured":"Slot, J. W., Geuze, H. J., Gigengack, S., James, D. E. & Lienhard, G. E. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc. Natl Acad. Sci. USA 88, 7815\u20137819 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15978_CR30","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2337\/diabetes.49.10.1714","volume":"49","author":"R Nagai","year":"2000","unstructured":"Nagai, R. et al. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49, 1714\u20131723 (2000).","journal-title":"Diabetes"},{"key":"15978_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.bbrc.2016.01.126","volume":"470","author":"S-H Choi","year":"2016","unstructured":"Choi, S.-H., Kim, J., Gonen, A., Viriyakosol, S. & Miller, Y. I. MD-2 binds cholesterol. Biochem. Biophys. Res. Commun. 470, 877\u2013880 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"15978_CR32","doi-asserted-by":"publisher","first-page":"12156","DOI":"10.1073\/pnas.211445098","volume":"98","author":"A Visintin","year":"2001","unstructured":"Visintin, A., Mazzoni, A., Spitzer, J. A. & Segal, D. M. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc. Natl Acad. Sci. USA 98, 12156\u201312161 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15978_CR33","doi-asserted-by":"publisher","first-page":"e68871","DOI":"10.1371\/journal.pone.0068871","volume":"8","author":"J Tang","year":"2013","unstructured":"Tang, J. et al. MyD88-dependent pathways in leukocytes affect the retina in diabetes. PLoS ONE 8, e68871 (2013).","journal-title":"PLoS ONE"},{"key":"15978_CR34","doi-asserted-by":"crossref","unstructured":"Takeuchi, M. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker for the onset\/progression of lifestyle-related diseases. Diagnostics 6, 23 (2016).","DOI":"10.3390\/diagnostics6020023"},{"key":"15978_CR35","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/01.RES.0000103862.26506.3D","volume":"93","author":"SF Yan","year":"2003","unstructured":"Yan, S. F., Ramasamy, R., Naka, Y. & Schmidt, A. M. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ. Res. 93, 1159\u20131169 (2003).","journal-title":"Circ. Res."},{"key":"15978_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","volume":"212","author":"H Yang","year":"2015","unstructured":"Yang, H. et al. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J. Exp. Med. 212, 5\u201314 (2015).","journal-title":"J. Exp. Med."},{"key":"15978_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1189\/jlb.1206751","volume":"82","author":"K Herold","year":"2007","unstructured":"Herold, K. et al. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J. Leukoc. Biol. 82, 204\u2013212 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"15978_CR38","doi-asserted-by":"publisher","first-page":"e23132","DOI":"10.1371\/journal.pone.0023132","volume":"6","author":"M Sakaguchi","year":"2011","unstructured":"Sakaguchi, M. et al. TIRAP, an adaptor protein for TLR2\/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS ONE 6, e23132 (2011).","journal-title":"PLoS ONE"},{"key":"15978_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00125-004-1392-9","volume":"47","author":"JV Valencia","year":"2004","unstructured":"Valencia, J. V., Mone, M., Koehne, C., Rediske, J. & Hughes, T. E. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia 47, 844\u2013852 (2004).","journal-title":"Diabetologia"},{"key":"15978_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","volume":"18","author":"T Miki","year":"2013","unstructured":"Miki, T., Yuda, S., Kouzu, H. & Miura, T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 18, 149\u2013166 (2013).","journal-title":"Heart Fail Rev."},{"key":"15978_CR41","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1182\/blood-2007-06-097782","volume":"111","author":"P Tissieres","year":"2008","unstructured":"Tissieres, P. et al. Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria. Blood 111, 2122\u20132131 (2008).","journal-title":"Blood"},{"key":"15978_CR42","doi-asserted-by":"publisher","first-page":"34698","DOI":"10.1074\/jbc.M405444200","volume":"279","author":"MN Kennedy","year":"2004","unstructured":"Kennedy, M. N. et al. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J. Biol. Chem. 279, 34698\u201334704 (2004).","journal-title":"J. Biol. Chem."},{"key":"15978_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cellimm.2008.08.009","volume":"255","author":"S Lauer","year":"2009","unstructured":"Lauer, S., Kunde, Y. A., Apodaca, T. A., Goldstein, B. & Hong-Geller, E. Soluble MD2 increases TLR4 levels on the epithelial cell surface. Cell Immunol. 255, 8\u201316 (2009).","journal-title":"Cell Immunol."},{"key":"15978_CR44","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.1139111","volume":"316","author":"U Ohto","year":"2007","unstructured":"Ohto, U., Fukase, K., Miyake, K. & Satow, Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316, 1632\u20131634 (2007).","journal-title":"Science"},{"key":"15978_CR45","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.imbio.2015.06.016","volume":"220","author":"Z Lu","year":"2015","unstructured":"Lu, Z., Zhang, X., Li, Y., Lopes-Virella, M. F. & Huang, Y. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes. Immunobiology 220, 1246\u20131254 (2015).","journal-title":"Immunobiology"},{"issue":"Suppl 1","key":"15978_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/10715762.2013.815348","volume":"47","author":"G Vistoli","year":"2013","unstructured":"Vistoli, G. et al. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic. Res. 47(Suppl 1), 3\u201327 (2013).","journal-title":"Free Radic. Res."},{"key":"15978_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1172\/JCI117296","volume":"94","author":"I Giardino","year":"1994","unstructured":"Giardino, I., Edelstein, D. & Brownlee, M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J. Clin. Invest. 94, 110\u2013117 (1994).","journal-title":"J. Clin. Invest."},{"key":"15978_CR48","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1039\/C8SC02578A","volume":"9","author":"M Yang","year":"2018","unstructured":"Yang, M., Fan, J., Zhang, J., Du, J. & Peng, X. Visualization of methylglyoxal in living cells and diabetic mice model with a 1,8-naphthalimide-based two-photon fluorescent probe. Chem. Sci. 9, 6758\u20136764 (2018).","journal-title":"Chem. Sci."},{"key":"15978_CR49","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson, M. et al. A simplified, langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ. Res. 119, 909\u2013920 (2016).","journal-title":"Circ. Res."},{"key":"15978_CR50","doi-asserted-by":"publisher","unstructured":"G\u00fcnd\u00fcz, D., Hamm, C. W. & Aslam, M. Simultaneous isolation of high quality cardiomyocytes, endothelial cells, and fibroblasts from an adult rat heart. JoVE https:\/\/doi.org\/10.3791\/55601 (2017).","DOI":"10.3791\/55601"},{"key":"15978_CR51","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.bbadis.2015.02.011","volume":"1852","author":"P Zhong","year":"2015","unstructured":"Zhong, P. et al. Blockage of ROS and NF-kappaB-mediated inflammation by a new chalcone L6H9 protects cardiomyocytes from hyperglycemia-induced injuries. Biochimica et. Biophysica Acta 1852, 1230\u20131241 (2015).","journal-title":"Biochimica et. Biophysica Acta"},{"key":"15978_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2015.02.029","volume":"82","author":"D Liang","year":"2015","unstructured":"Liang, D. et al. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model. J. Mol. Cell. Cardiol. 82, 63\u201374 (2015).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"15978_CR53","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.2337\/db13-0039","volume":"62","author":"MP Bhatt","year":"2013","unstructured":"Bhatt, M. P., Lim, Y. C., Kim, Y. M. & Ha, K. S. C-peptide activates AMPKalpha and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes. Diabetes 62, 3851\u20133862 (2013).","journal-title":"Diabetes"},{"key":"15978_CR54","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/01.RES.0000091828.36599.34","volume":"93","author":"NG Abraham","year":"2003","unstructured":"Abraham, N. G. et al. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ. Res. 93, 507\u2013514 (2003).","journal-title":"Circ. Res."},{"key":"15978_CR55","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1248\/bpb.29.1110","volume":"29","author":"K Hayashi","year":"2006","unstructured":"Hayashi, K., Kojima, R. & Ito, M. Strain differences in the diabetogenic activity of streptozotocin in mice. Biol. Pharm. Bull. 29, 1110\u20131119 (2006).","journal-title":"Biol. Pharm. Bull."},{"key":"15978_CR56","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0041-1345(97)01425-5","volume":"30","author":"WT Lu","year":"1998","unstructured":"Lu, W. T., Juang, J. H., Hsu, B. R. & Huang, H. S. Effects of high or low dose of streptozocin on pancreatic islets in C57BL\/6 and C.B17-SCID mice. Transpl. Proc. 30, 609\u2013610 (1998).","journal-title":"Transpl. Proc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15978-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15978-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15978-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:20:44Z","timestamp":1670257244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15978-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["15978"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-15978-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2148"}}